Regulatory Affairs

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO

CAMBRIDGE, Mass.--(BUSINESS WIRE)--DEM BioPharma, Inc. (DEM Bio), an oncology company developing therapies that target signals on cancer cells and macrophages to eliminate tumors, established...

Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660

SAINT-PREX, Switzerland & PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and...

Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR-NK for the Treatment of Solid Tumors

SAN DIEGO--(BUSINESS WIRE)--Artiva Biotherapeutics, Inc., a clinical stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies that...

Recent Articles

Get a free copy of "Cracking the Generics Code"

Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.